Search

...the body’s anti-cancer immune response, as has been seen in tests on mice. If positive results are seen with pancreatic tumours, the team will develop the treatment further through the...

...and engineering antibodies that bind to them, stimulating an immune response against the tumour. To date, Professor Durrant and her team have engineered five novel antibodies that are specific to...

Professor Seymour’s project aims to develop a virus that will specifically infect and break down pancreatic cancer cells and activate the immune system to help kill the cancer. Immunotherapy has...

Project title: PARP molecular imaging in pancreatic cancer (PARP-PET in PDAC) Project aims: Dr Cornelissen has attached a radioactive atom to a chemotherapy drug and will test whether PET scanners...

...the chain of events leading to cancer spread, since only a small proportion of these cancer cells are able to successfully grow at distant sites. This new project aims to...

...treasure.” Andy added: “It was an overwhelming afternoon. The whole show was brilliant and it was such a happy, friendly and supportive crowd who were so generous and really raised...

Project title: A new approach to drugging intractable targets for the treatment of pancreatic cancer Project aims: Cells stay healthy by tagging faulty proteins with a molecule called ubiquitin that...

...73 projects have been funded, with a total value of over £15.6 million. These are focused on early diagnosis of pancreatic cancer and the development and monitoring of new treatments....

...identified a way to potentially allow chemotherapy to be more effective with pancreatic cancer, and this will involve a deeper understanding of the cells that help to form the stroma....

Project title: Identification of drugs that promote activation of the host anticancer immune-responses through enhancement of virus-mediated cell lysis Project aims: Professor Halldén is progressing her PCRF-funded research which aims...